惠生國際(01340.HK)擬成立生豬屠宰合資 另配股淨籌213萬元
惠生國際(01340.HK)公布,於11月30日間接全資附屬湖南惠生與合資夥伴訂立合資協議,於湖南省成立合資企業,註冊資本為1,000萬元人民幣,當中湖南惠生及合資夥伴分別擁有合資企業的60%和40%股本權益。待完成合資協議後,合資企業將會成為公司附屬。
惠生國際指,合資企業擬主要從事生豬屠宰,料可以於本年年末或明年年初開始試運行,而當其開始批量營運時將可改善集團的生產效率以及降低生產成本。
另外,公司向獨立第三方伍國柱訂立認購協議,認購股份為4,200萬股,相當於擴大公司已發行股本的約4.55%,每股認購價0.053元,較昨日收市價折讓8.6%。認購事項之所得款項淨額213萬元,將會用作補充集團用作支付服務費之資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.